comparemela.com
  1. Home
  2. Live Updates
  3. Denis Corin - Breaking News

Denis Corin News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Q BioMed Inc Chemotherapeutic Uttroside B, Receives Patent from United States Patent Office and Notice of Allowance for Europe

Company s Liver Cancer Drug Candidate IP Portfolio strengthened Company provides operational update on strategic opportunities NEW YORK, April 14, 2023 /PRNewswire/  Q BioMed Inc. a biotech. | April 14, 2023

United statesKeith pinderDenis corinCq biomed incOklahoma medical research foundationSourceq biomed incQbiomed incDepartment of biotechnologySecurities exchangeMannin researchRajiv gandhi centre for biotechnologyAutonomous instituteAmerica cancer societyCompany liver cancer drugLiver cancer drug candidateLiver cancer market

Q BioMed Inc Chemotherapeutic Uttroside B, Receives Notice of Allowance for Patent from United States Patent Office

/PRNewswire/ Q BioMed Inc. (OTCQB: QBIO) a biotech acceleration and commercial stage company focused on licensing and acquiring undervalued biomedical.

United statesQ biomed uttrosideDenis corinKeith pinderAmerica cancer societyCq biomed incSourceq biomed incDepartment of biotechnologyRajiv gandhi centre for biotechnologyOklahoma medical research foundationAutonomous instituteSecurities exchangeUttrosideb has shown promising resultsInitial pre clinicalLiver cancerOrphan drug

Form PRE 14C Q BioMed Inc For: Nov 18

Form PRE 14C Q BioMed Inc For: Nov 18
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

New yorkUnited statesState of nevadaWilliam rosenstadtDenis corinCq biomed incCq biomed incExchange act ruleExchange commissionExchange actStock of the companyOrtoli rosenstadtFiling partySecurities exchangeStatement pursuantSecurities exchange act

Q BioMed Inc boosted by multi-million dollar asset as it converts long-term royalty into equity stake in Mannin Research

Q BioMed Inc has given itself a big shot in the arm, adding a multi-million dollar asset in the form of an equity stake in long term partner Mannin.

George nikopoulosDenis corinMannin researchCq biomed inc

Q BIOMED ANNOUNCES ADDITION OF MULTI-MILLION DOLLAR ASSET VALUE WITH EQUITY STAKE IN MANIIN RESEARCH INC

/PRNewswire/ Q BioMed Inc. (QBIO), a commercial stage biotechnology acceleration development company, is pleased to announce that it has converted its.

Georgen nikopoulosSusan quagginDenis corinKeith pinderPrnewswireq biomed incSecurities exchangeCq biomed incSourceq biomed incMannin research incMannin researchResearch incLooking statementsSecurities actSecurities exchange actBiomed media contactCq biomed inc

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.